Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette

Pretreatment p53 Nuclear Overexpression as a Prognostic Marker in Superficial Bladder Cancer Treated with Bacillus Calmette–Guérin (BCG)

Published:2004-04 Issue:4 Volume:45 Page:475-482
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Saint Fabien,Le Frere Belda Marie-Aude,Quintela Rodrigo,Hoznek Andras,Patard Jean-Jacques,Bellot Jacqueline,Popov Zivko,Zafrani Elie S.,Abbou Claude C.,Chopin Dominique K.,Gil Diez de Medina Sixtina

Publisher

Elsevier BV

Subject

Urology

Reference37 articles.

1. Intracavity Bacillus Calmette–Guérin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976

2. Bacillus Calmette–Guérin therapy alters the progression of superficial bladder cancer;Herr;J. Clin. Oncol.,1988

3. Analysis of early failures after intravesical instillation therapy with Bacillus Calmette–Guérin for carcinoma in situ of the bladder;Merz;Br. J. Urol.,1995

4. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?;Herr;J. Urol.,2001

5. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation;Yiou;BJU Int.,2002

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review;Pharmacological Research;2024-08

2. Metabolomic Biomarkers for Prognosis in Non-Muscle Invasive Bladder Cancer: A Comprehensive Systematic Review and Meta-Analysis;Indian Journal of Clinical Biochemistry;2024-02-09

3. Mini-Review: Current Bladder Cancer Treatment—The Need for Improvement;International Journal of Molecular Sciences;2024-01-26

4. Clinico-Pathological Features and Immunohistochemical Comparison of p16, p53, and Ki-67 Expression in Muscle-Invasive and Non-Muscle-Invasive Conventional Urothelial Bladder Carcinoma;Clinics and Practice;2023-07-09

5. The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma;Clinical and Translational Oncology;2022-11-14